Effect of introduction of intermittently scanned continuous glucose monitoring on glycaemic control in individuals living with type 2 diabetes mellitus treated with non‐insulin therapies—A randomised controlled trial

Documenti analoghi

• Baseline clinical factors associated with diabetes distress in dialysis patients: Insights from the ABCD audit data
  di: Emmanuel Ssemmondo, et al.
  Pubblicazione: (2025)
• Clinical features of type 1 diabetes in older adults and the impact of intermittently scanned continuous glucose monitoring: An Association of British Clinical Diabetologists (ABCD) study
  di: Harshal Deshmukh, et al.
  Pubblicazione: (2024)
• Efficacy and safety of continuous glucose monitoring on glycaemic control in patients with chronic pancreatitis and insulin‐treated diabetes: A randomised, open‐label, crossover trial
  di: Line Davidsen, et al.
  Pubblicazione: (2025)
• The efficacy of intermittent scanning continuous glucose monitoring in the elderly: A case–control study
  di: Riemer A. Been, et al.
  Pubblicazione: (2025)
• Biweekly dosing of efsubaglutide alfa maintains glycaemic and continuous glucose monitoring control in type 2 diabetes: A randomised multicentre trial
  di: Rui Sun, et al.
  Pubblicazione: (2025)